Company: CRVO
Filing Date: 2025-05-12
Form Type: 424B5
Source: 0001437749-25-016167
Chunk: 32

Company: CervoMed Inc.
Filing Date: 2025-05-12
Form: 424B5
Chunk 32
---
 of such securities, with a total aggregate offering price of up to $250,000,000, from time to time and at prices and on terms to be determined by market conditions at the time of offering. This prospectus provides you with a general description of the securities we may offer. Each time we offer a type or series of securities, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable:

| • | designation or classification; |

| • | aggregate principal amount or aggregate offering price; |

<div align='center'>4</div>

| • | maturity, if applicable; |

| • | original issue discount, if any; |

| • | rates and times of payment of interest or dividends, if any; |

| • | redemption, conversion, exchange or sinking fund terms, if any; |

| • | conversion or exchange prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion or exchange prices or rates and in the securities or other property receivable upon conversion or exchange; |

| • | ranking, if any; |

| • | restrictive covenants, if any; |

| • | voting or other rights, if any; and |

| • | important United States federal income tax considerations. |

A prospectus supplement and any related free writing prospectus that we may provide or authorize to be provided to you may also add, update, or change information contained in this prospectus or in documents we have incorporated by reference. However, no prospectus supplement or free writing prospectus will offer a security that is not registered and described in this prospectus at the time of the effectiveness of the registration statement of which this prospectus is a part.

We may sell the securities directly to or through underwriters, dealers or agents. We, and our underwriters or agents, reserve the right to accept or reject all or part of any proposed purchase of securities. If we do offer securities through underwriters or agents, we will include in the applicable prospectus supplement:

| • | the names of those underwriters or agents; |

| • | applicable fees, discounts and commissions to be paid to them; |

| • | details regarding over-allotment options or refreshable options, if any; and |

| • | the net proceeds to us. |

<div align='center'>5

RISK FACTORS</div>

Investing in our securities involves a high degree of risk